Chikungunya: Phase 3 Clinical Development of a Single-shot Live-Attenuated Vaccine (Presentation at the American Society of Tropical Medicine & Hygiene)

(marketscreener.com) Chikungunya: Phase 3 clinical development of a single-shotlive-attenuated vaccine candidate American Society of Tropical Medicine & Hygiene Vera Bürger Director Clinical Strategy, Project Lead Chikungunya Vaccine Development ...https://www.marketscreener.com/quote/stock/VALNEVA-SE-54466/news/Chikungunya-Phase-3-Clinical-Development-of-a-Single-shot-Live-Attenuated-Vaccine-Presentation-at-42172171/?utm_medium=RSS&utm_content=20221102